West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 91/100

West Pharmaceutical Services Inc at Stephens Investment Conference Transcript

Nov 16, 2023 / 02:00PM GMT
Release Date Price: R$49
Jacob K. Johnson;Quintin J. Lai
Stephens Inc., Research Division - MD & Analyst;West Pharmaceutical

All right. Good morning, everybody. Welcome to the first fireside chat of the last day of the Stephens Investment Conference. I'm Jacob Johnson, Life Science Tools and Pharma Services analyst here at Stephens. Thanks, everybody, for joining us this morning. Great way to kick off the day to have the team from West with us.

We've got -- we have the whole crew. We have Cindy Reiss-Clark, the Chief Commercial Officer; Chad Winters, Chief Accounting Officer; and Quintin Lai, VP of Corporate Development and Investor Relations.

This will be a fireside chat format. So I'll be asking questions, but I'll try to pause along the way in case anybody in the audience has questions. Just if the audience asks any questions, I'll try to repeat it for those listening on webcast.

So with that preamble out of the way, Quintin or Cindy or Chad, whoever wants to take it, I'll turn it over to you for any introductory comments, and then we'll start the Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot